| Filed On | Filing |
|---|---|
| 05 Oct 2026 |
Form 3: Mitin Yury, See Remarks
No securities owned |
| 17 Apr 2026 |
Form 3: Kaiser Brittany, Director
No securities owned |
| 09 Apr 2026 |
Form 3: Terpin Michael, Director
No securities owned |
| 07 Apr 2026 |
Form 3: Villani Fiorenzo, Director
Holds 143,000 shares of Ordinary Shares |
| 18 Mar 2026 |
Form 3: Levitt Wesley Allen, Chief Financial Officer
No securities owned |
| 03 May 2017 |
Form 3: Portage Biotech Inc., 10% owner · Biohaven Pharmaceutical Holding Co Ltd.
Holds 6,341,500 shares of Common Shares |
Loading...
